文献速递细胞病理与分子病理神经与头颈病理

米兰系统报告涎腺细胞病理学的系统评价与荟萃分析

Application of the Milan System for Reporting Salivary Gland Cytopathology: A systematic review and meta-analysis.
PubMed 文献 · Cancer Cytopathol · 2022-05-30

各诊断类别恶性肿瘤风险(ROM)从2.8%到97.7%不等,鉴别良恶性的敏感性88.0%、特异性98.5%、诊断比值比520.3。结论认为MSRSGC诊断准确性高,除「可疑恶性」类别ROM显著高于参考值外,其余与推荐一致。

要点

  • MSRSGC各诊断类别ROM从2.8%(良性肿瘤)到97.7%(恶性)不等。
  • 鉴别良恶性病变的敏感性88.0%、特异性98.5%、诊断比值比520.3。
  • 「可疑恶性」类别ROM为83.8%,显著高于参考值。

核心结论

  • 使用MSRSGC报告SG-FNA显示出高诊断准确性。
  • 各诊断类别ROM总体与推荐一致,但「可疑恶性」类别ROM显著高于参考值。
  • 分层标准化分类系统有助于涎腺病变的临床管理。

研究设计与样本

  • 系统评价与荟萃分析,全面回顾MSRSGC发布后的队列研究。
  • 计算各诊断类别的肿瘤风险与恶性肿瘤风险(ROM),并评估诊断效能。

主要发现

  • ROM:不可诊断11.4%;非肿瘤性10.9%;意义未定的异型性30.5%;肿瘤-良性2.8%;肿瘤-涎腺肿瘤恶性潜能未定37.7%;可疑恶性83.8%;恶性97.7%。
  • ROM估计观察到低水平异质性。
  • 鉴别良恶性病变的敏感性88.0%、特异性98.5%、诊断比值比520.3。

关键数值与推荐

  • 各诊断类别ROM数值如上,其中「可疑恶性」类别ROM为83.8%,显著高于参考值。

临床怎么用

  • 采用MSRSGC对SG-FNA进行分层标准化报告,可支持涎腺病变的临床管理。
  • 注意「可疑恶性」类别实际ROM高于参考值,临床解读时应结合具体情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) is a standard, evidence-based classification system for salivary gland fine-needle aspiration (SG-FNA). Since it was published in 2018, many researchers across the world have applied this uniform reporting system to their cohorts. METHODS: The authors comprehensively reviewed cohort studies conducted since publication of the MSRSGC and performed a meta-analysis. The risk of neoplasm and the risk of malignancy (ROM) were calculated for each diagnostic category, and their diagnostic efficacy was evaluated. RESULTS: Thirty-five studies were included in the meta-analysis. The total number of SG-FNAs was 10,706, and 7168 of those had histopathologic follow-up. The ROM for each category was: nondiagnostic, 11.4%; nonneoplastic, 10.9%; atypia of undetermined significance, 30.5%; neoplasm-benign, 2.8%; neoplasm-salivary gland neoplasm of uncertain malignant potential, 37.7%; suspicious for malignancy, 83.8%; and malignant, 97.7%. Low-level heterogeneity was observed in ROM estimation. The sensitivity, specificity, and diagnostic odds ratio for differentiating malignant and benign lesions were 88.0%, 98.5% and 520.3, respectively. CONCLUSIONS: The reporting of SG-FNA using the MSRSGC demonstrated high diagnostic accuracy. The ROM for each category was generally concordant with the recommendations, except for the suspicious for malignancy category, which was significantly higher than the reference value. The tiered, standardized classification system would benefit the clinical management of salivary gland lesions.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Wang Z, Zhao H, Guo H, et al. Application of the Milan System for Reporting Salivary Gland Cytopathology: A systematic review and meta-analysis. Cancer Cytopathol. 2022. PMID: 35637572. doi:10.1002/cncy.22604

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。